SERA Prognostics, Inc.
SERA Prognostics, Inc. is listed today as Sera Prognostics, Inc.: market value, financials and filings are on its company page.
Funding rounds
6 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2021 | $100 M | No. 6 | $50 to $250 million | equity, debt, options | SEC | |
| Jul 2019 | $52 M | No. 5 | $50 to $250 million | equity, debt, options | SEC | |
| Jan 2017 | $23 M | No. 4 | $10 to $50 million | equity | SEC | |
| Nov 2014 | $5 M | No. 3 | $2 to $10 million | equity | SEC | |
| May 2014 | $9 M | No. 2 | $2 to $10 million | equity | SEC | |
| Nov 2011 | $10 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
SERA Prognostics, Inc. chose not to state its revenue in its newest notice of a funding round (May 2021).
SEC Form D · May 2021
The industry group it chose in its notices: Other Health Care.
SEC Form D · May 2021
That is all the official record says: SERA Prognostics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of SERA Prognostics, Inc. are on record.
Investors#
6 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Blue Ox Healthcare Partners, LLC | Fund or asset manager | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Blue Ox Healthcare Partners SP, LLC | Fund or asset manager | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Bxhcp SP III, LLC | Other | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Bxhcp SP II, LLC | Other | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Gregory C. Critchfield | Person | not stated | not stated | Held Series A-2, B-1, B-2, C-1 and D preferred stock, director (Form 3, 2021) | SEC Form 3 |
| Jay M. Moyes | Person | not stated | not stated | Held Series A-2 and B-1 preferred stock (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 28 investors.
Largest shareholders today
Institutions holding Sera Prognostics, Inc. shares, as of Sep 30, 2026.
- Baker Bros. Advisors LP$11 M13.63%
- Whetstone Capital Advisors, LLC$7 M8.20%
- Aberdeen Group plc$6 M7.32%
- PSP Research LLC$5 M5.94%
- Vivo Capital, LLC$3 M4.09%
- Vanguard Capital Management LLC$3 M3.22%
- Geode Capital Management, LLC$1 M0.87%
- Sanders Morris Harris LLC$1 M0.78%
- Captrust Financial Advisors$1 M0.76%
- BlackRock, Inc.$0 M0.55%
- Vanguard Fiduciary Trust Co$0 M0.52%
- AWM Investment Company, Inc.$0 M0.51%
- State Street Corp$0 M0.31%
- Perigon Wealth Management, LLC$0 M0.18%
- Northern Trust Corp$0 M0.17%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Douglas B. Fisher | Executive officer | May 2021 |
| Gregory C. Critchfield | Executive officer | May 2021 |
| Jay C. Moyes | Executive officer | May 2021 |
| Andrew A. Sauter | Executive officer | Feb 2020 |
| Mark J. Ostrowski | Executive officer | Nov 2011 |
| Charles M. Kennedy | Director | May 2021 |
| Dennis B. Farrar | Director | May 2021 |
| Elizabeth B. Canis | Director | May 2021 |
| Gregory C. Critchfield | Director | May 2021 |
| Joseph M. Siletto | Director | May 2021 |
| Joshua B. Phillips | Director | May 2021 |
| Kim B. Kamdar | Director | May 2021 |
| Mansoor M. Mirza | Director | May 2021 |
| Marcus M. Wilson | Director | May 2021 |
| Michael M. Minahan | Director | May 2021 |
| Ryan M. Trimble | Director | May 2021 |
| Arnold B. Oronsky, Ph.D. | Director | Feb 2020 |
| Charles D. Kennedy | Director | Feb 2020 |
| Mansoor Raza Mirza | Director | Feb 2020 |
| Michael Raza Minahan | Director | Feb 2020 |
| Douglas B. Fisher | Director | Nov 2014 |
| Joshua L. Phillips | Director | Nov 2014 |
| Richard L. Novak | Director | Nov 2014 |
| Douglas M. Fisher | Director | Jun 2014 |
| Joshua M. Phillips | Director | Jun 2014 |
| Kim M. Kamdar | Director | Jun 2014 |
Went public since 2021. Its SEC number is that of a company listed on a stock exchange.